Researchers at McMaster University in Canada recently published a paper describing how cannabigerol, the common cannabinoid known as CBG, killed a variety of strains of MRSA, the antibiotic-resistant staph bacteria.

The researchers, led by Eric D. Brown, went further than previous studies by moving beyond the petri dish and testing CBD on rodents.

Their results could be the first step in making CBG the newest antibiotic on the market.

Click here to read the complete article

Zoe Sigman ~ Leafly.com ~